IDR 400.0
(-1.48%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1058.88 Billion IDR | 44.28% |
2022 | 733.92 Billion IDR | -6.15% |
2021 | 782.04 Billion IDR | 46.1% |
2020 | 535.27 Billion IDR | 64.48% |
2019 | 325.43 Billion IDR | 138.83% |
2018 | 136.26 Billion IDR | 6.73% |
2017 | 127.67 Billion IDR | 369.36% |
2016 | 27.2 Billion IDR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1071.78 Billion IDR | 1.22% |
2024 Q2 | 1201.37 Billion IDR | 12.09% |
2024 Q3 | 1491.12 Billion IDR | 24.12% |
2023 Q3 | 703.59 Billion IDR | -6.48% |
2023 Q2 | 752.37 Billion IDR | 11.58% |
2023 FY | 1058.88 Billion IDR | 44.28% |
2023 Q1 | 674.29 Billion IDR | -8.13% |
2023 Q4 | 1058.88 Billion IDR | 50.5% |
2022 Q2 | 892.23 Billion IDR | 15.32% |
2022 Q4 | 733.92 Billion IDR | -5.57% |
2022 Q3 | 777.22 Billion IDR | -12.89% |
2022 Q1 | 773.69 Billion IDR | -1.07% |
2022 FY | 733.92 Billion IDR | -6.15% |
2021 Q1 | 728.73 Billion IDR | 36.14% |
2021 FY | 782.04 Billion IDR | 46.1% |
2021 Q4 | 782.04 Billion IDR | -12.89% |
2021 Q3 | 897.76 Billion IDR | -7.93% |
2021 Q2 | 975.05 Billion IDR | 33.8% |
2020 FY | 535.27 Billion IDR | 64.48% |
2020 Q4 | 535.27 Billion IDR | 117.95% |
2020 Q3 | 245.59 Billion IDR | -9.21% |
2020 Q2 | 270.52 Billion IDR | -9.86% |
2020 Q1 | 300.12 Billion IDR | -7.78% |
2019 Q4 | 325.43 Billion IDR | 0.0% |
2019 Q1 | 97.29 Billion IDR | 0.0% |
2019 FY | 325.43 Billion IDR | 138.83% |
2018 FY | 136.26 Billion IDR | 6.73% |
2018 Q1 | - IDR | 0.0% |
2017 FY | 127.67 Billion IDR | 369.36% |
2016 FY | 27.2 Billion IDR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
PT Enseval Putera Megatrading Tbk. | 10955.84 Billion IDR | 90.335% |
PT Kimia Farma (Persero) Tbk | 17585.29 Billion IDR | 93.979% |
PT Millennium Pharmacon International Tbk | 1639.68 Billion IDR | 35.421% |
PT Soho Global Health Tbk | 4746.96 Billion IDR | 77.693% |